Medical Research
(H124)
IRS Verified
DX Registered
990 on File
LUNGEVITY FOUNDATION
Financial strength (30%)
78/100
Reliability (20%)
70/100
Effectiveness (25%)
97/100
Impact (25%)
No data yet
Register and add impact metrics to be rated above three stars
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$14.2M
Total Revenue
$14.6M
Total Expenses
$5.2M
Net Assets
60
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
85.1%
Fundraising Efficiency
1623.1%
Operating Reserve
4.30x
Liability-to-Asset
15.5%
Revenue Diversification
102.7%
Executive Compensation
$484K
Compared with Peers
FY 2025
Compared with 35 similar organizations
(United States, Medical Research, $10M–$100M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
85.1% | 82.0% |
P10P90
|
Above median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
4.7% | 9.0% |
P10P90
|
Above median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
10.2% | 0.2% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
1623.1% | 1042.4% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
4.3 mo | 17.6 mo |
P10P90
|
Bottom quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
15.5% | 22.9% |
P10P90
|
Above median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
102.7% | 84.9% |
P10P90
|
Bottom quarter |
|
Revenue growth
Year over year revenue growth
|
3.5% | 9.8% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-8.5% | 6.0% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-2.2% | 4.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $14.2M | $14.6M | $5.2M | 85.1% | 60 |
| 2024 | $13.8M | $15.9M | $5.5M | 86.6% | 65 |
| 2023 | $14.4M | $18.4M | $7.7M | 87.0% | 72 |
| 2022 | $14.5M | $13.7M | N/A | — | 46 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.